These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

794 related items for PubMed ID: 25567207

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. SOX4 overexpression is a novel biomarker of malignant status and poor prognosis in breast cancer patients.
    Song GD, Sun Y, Shen H, Li W.
    Tumour Biol; 2015 Jun; 36(6):4167-73. PubMed ID: 25592378
    [Abstract] [Full Text] [Related]

  • 3. Elevated expression of HMGA1 correlates with the malignant status and prognosis of non-small cell lung cancer.
    Zhang Z, Wang Q, Chen F, Liu J.
    Tumour Biol; 2015 Feb; 36(2):1213-9. PubMed ID: 25344216
    [Abstract] [Full Text] [Related]

  • 4. [Expression of transcription factor SOX4 and its clinical significance in female lung cancer patients in Xuanwei area, Yunnan Province].
    Zhou YC, Wang XC, Chen Y, Zhang LJ, Liu X, Yao Q, Chen XQ, Zhao GQ, Huang YC.
    Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):202-6. PubMed ID: 23880001
    [Abstract] [Full Text] [Related]

  • 5. Clinicopathologic features and prognostic implications of Gankyrin protein expression in non-small cell lung cancer.
    Wang WP, Yan XL, Li WM, Ni YF, Zhao JB, Lu Q, Wang XJ, Sun Y, Chen P, Yan BY, Cui Y, Zhang ZP, Li XF.
    Pathol Res Pract; 2015 Dec; 211(12):939-47. PubMed ID: 26554593
    [Abstract] [Full Text] [Related]

  • 6. MDK Protein Overexpression Correlates with the Malignant Status and Prognosis of Non-small Cell Lung Cancer.
    Yuan K, Chen Z, Li W, Gao CE, Li G, Guo G, Yang Y, Ai Y, Wu L, Zhang M.
    Arch Med Res; 2015 Nov; 46(8):635-41. PubMed ID: 26656665
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Prognostic significance of MCM7 expression in the bronchial brushings of patients with non-small cell lung cancer (NSCLC).
    Liu YZ, Jiang YY, Hao JJ, Lu SS, Zhang TT, Shang L, Cao J, Song X, Wang BS, Cai Y, Zhan QM, Wang MR.
    Lung Cancer; 2012 Jul; 77(1):176-82. PubMed ID: 22456526
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Expression and significance of hypoxia inducible factor-1α and lysyl oxidase in non-small cell lung cancer.
    Ping W, Jiang WY, Chen WS, Sun W, Fu XN.
    Asian Pac J Cancer Prev; 2013 Jul; 14(6):3613-8. PubMed ID: 23886154
    [Abstract] [Full Text] [Related]

  • 12. Prognostic significance of 14-3-3γ overexpression in advanced non-small cell lung cancer.
    Raungrut P, Wongkotsila A, Lirdprapamongkol K, Svasti J, Geater SL, Phukaoloun M, Suwiwat S, Thongsuksai P.
    Asian Pac J Cancer Prev; 2014 Jul; 15(8):3513-8. PubMed ID: 24870749
    [Abstract] [Full Text] [Related]

  • 13. The clinical significance of FSCN1 in non-small cell lung cancer.
    Luo A, Yin Y, Li X, Xu H, Mei Q, Feng D.
    Biomed Pharmacother; 2015 Jul; 73():75-9. PubMed ID: 26211585
    [Abstract] [Full Text] [Related]

  • 14. Down-regulated MicroRNA 148b expression as predictive biomarker and its prognostic significance associated with clinicopathological features in non-small-cell lung cancer patients.
    Ghasemkhani N, Shadvar S, Masoudi Y, Talaei AJ, Yahaghi E, Goudarzi PK, Shakiba E.
    Diagn Pathol; 2015 Sep 17; 10():164. PubMed ID: 26377406
    [Abstract] [Full Text] [Related]

  • 15. CD24, a novel cancer biomarker, predicting disease-free survival of non-small cell lung carcinomas: a retrospective study of prognostic factor analysis from the viewpoint of forthcoming (seventh) new TNM classification.
    Lee HJ, Choe G, Jheon S, Sung SW, Lee CT, Chung JH.
    J Thorac Oncol; 2010 May 17; 5(5):649-57. PubMed ID: 20354454
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Clinical significance of SOX9 in human non-small cell lung cancer progression and overall patient survival.
    Zhou CH, Ye LP, Ye SX, Li Y, Zhang XY, Xu XY, Gong LY.
    J Exp Clin Cancer Res; 2012 Mar 03; 31(1):18. PubMed ID: 22385677
    [Abstract] [Full Text] [Related]

  • 18. The role of CD133 expression in the carcinogenesis and prognosis of patients with lung cancer.
    Le H, Zeng F, Xu L, Liu X, Huang Y.
    Mol Med Rep; 2013 Nov 03; 8(5):1511-8. PubMed ID: 24008862
    [Abstract] [Full Text] [Related]

  • 19. Beclin 1 and p62 expression in non-small cell lung cancer: relation with malignant behaviors and clinical outcome.
    Wang X, Du Z, Li L, Shi M, Yu Y.
    Int J Clin Exp Pathol; 2015 Nov 03; 8(9):10644-52. PubMed ID: 26617774
    [Abstract] [Full Text] [Related]

  • 20. Increased high-mobility group A2 correlates with lymph node metastasis and prognosis of non-small cell lung cancer.
    Guo X, Shi J, Wen Y, Li M, Li Q, Li X, Li J.
    Cancer Biomark; 2018 Feb 14; 21(3):547-555. PubMed ID: 29278873
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 40.